Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Psoriasis (Auckl) ; 11: 41-51, 2021.
Article in English | MEDLINE | ID: mdl-34007822

ABSTRACT

BACKGROUND: The study of HLA classes I and II in Brazilian psoriasis patients may contribute to a better understanding of their association with the disease. OBJECTIVE: To describe HLA classes I and II of Brazilian patients with psoriasis, with or without arthritis, compare them to controls and correlate HLA markers with epidemiological and evolutional aspects of psoriasis. METHODS: A total of 55 patients with more than 5 years of psoriasis, with or without arthritis, answered a questionnaire on ethnic background and disease severity. A total of 134 bone marrow donors were controls. HLA class I and II genotyping was determined by PCR-SSP. RESULTS: Mean age was 42.4 years; 23 women and 32 men. HLA-B*57 was present in 23.6% patients and in 7.5% controls (p=0.00200, OR= 3.8381), and HLA-C*06 in 29.1% patients and in 16.4% controls (p= 0.04832, OR=2.0886). HLA-B*57 and HLA-C*18 were significantly present in patients with arthritis (p=0.00104, OR=6.6769 and p=0.00269, OR=16.50, respectively). HLA-B*57 was significantly present in patients with history of erythroderma (p=0.00548, OR= 5.1059), as was HLA-C*06 (p=0.02158, OR=3.0545). HLA-B*57 was also frequent in patients with history of hospital internment due to psoriasis (p= 0.00094, OR=7.8909) and in the ones with history of systemic treatment for psoriasis (p= 0.00011, OR= 5.3733). Haplotype HLA-A*02 B*57 C*06 DRB1*07DQB1*03 was the most common among the patients (p= 0.00069, OR= 3.528). CONCLUSION: HLA-B*57 and HLA-C*06 were significantly increased in the patients indicating risk for psoriasis. HLA-B*57 remained high in patients with history of erythroderma, hospital internment, systemic treatment, and psoriatic arthritis, showing association with disease severity. HLA-C*18 was significantly high only in patients with psoriatic arthritis. HLA-B*57 and HLA-C*06 and haplotype HLA-A*02B*57Cw*06DRB1*07 DQB1*03 seen in this study were already described before, associated with psoriasis. HLA-Cw*18 was not described in other populations in association with psoriasis.

4.
An Bras Dermatol ; 92(5 Suppl 1): 145-147, 2017.
Article in English | MEDLINE | ID: mdl-29267475

ABSTRACT

Pemphigus herpetiformis is an autoimmune bullous disease, that combines clinical features of dermatitis herpetiformis and linear IgA bullous dermatosis and immunological characteristics of pemphigus, which makes this disease peculiar and this diagnosis rarely suspected in the first evaluation of the patient. The reported case is of a patient with clinically bullous disease similar to dermatitis herpetiformis, whose multiple biopsies were inconclusive, and only after direct immunofluorescence with a pemphigus pattern (intraepidermal intercellular pattern) the confirmation of the diagnosis was possible.


Subject(s)
Dermatitis Herpetiformis/pathology , Fluorescent Antibody Technique, Direct/methods , Pemphigus/pathology , Adult , Biopsy , Erythema/pathology , Female , Humans
5.
An Bras Dermatol ; 92(3): 392-394, 2017.
Article in English | MEDLINE | ID: mdl-29186256

ABSTRACT

Angiolymphoid hyperplasia with eosinophilia is a rare and benign vascular tumor whose etiology remains uncertain. It clinically presents itself by angiomatous papules or nodules located on the head and neck. Many controversies in the literature are found in relation to angiolymphoid hyperplasia with eosinophilia and Kimura's disease - its main differential diagnosis - due to their clinical and histopathological similarities. However, currently, most studies agree that they are distinct diseases. The present case illustrates a characteristic description of angiolymphoid hyperplasia with eosinophilia and also highlights the main differences with Kimura's disease.


Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/pathology , Scalp Dermatoses/pathology , Aged , Angiolymphoid Hyperplasia with Eosinophilia/diagnosis , Diagnosis, Differential , Female , Humans , Scalp Dermatoses/diagnosis
6.
An. bras. dermatol ; 92(3): 392-394, May-June 2017. graf
Article in English | LILACS | ID: biblio-886965

ABSTRACT

Abstract Angiolymphoid hyperplasia with eosinophilia is a rare and benign vascular tumor whose etiology remains uncertain. It clinically presents itself by angiomatous papules or nodules located on the head and neck. Many controversies in the literature are found in relation to angiolymphoid hyperplasia with eosinophilia and Kimura's disease - its main differential diagnosis - due to their clinical and histopathological similarities. However, currently, most studies agree that they are distinct diseases. The present case illustrates a characteristic description of angiolymphoid hyperplasia with eosinophilia and also highlights the main differences with Kimura's disease.


Subject(s)
Humans , Female , Aged , Scalp Dermatoses/pathology , Angiolymphoid Hyperplasia with Eosinophilia/pathology , Scalp Dermatoses/diagnosis , Diagnosis, Differential , Angiolymphoid Hyperplasia with Eosinophilia/diagnosis
7.
An. bras. dermatol ; 92(5,supl.1): 145-147, 2017. graf
Article in English | LILACS | ID: biblio-887071

ABSTRACT

Abstract Pemphigus herpetiformis is an autoimmune bullous disease, that combines clinical features of dermatitis herpetiformis and linear IgA bullous dermatosis and immunological characteristics of pemphigus, which makes this disease peculiar and this diagnosis rarely suspected in the first evaluation of the patient. The reported case is of a patient with clinically bullous disease similar to dermatitis herpetiformis, whose multiple biopsies were inconclusive, and only after direct immunofluorescence with a pemphigus pattern (intraepidermal intercellular pattern) the confirmation of the diagnosis was possible.


Subject(s)
Humans , Female , Adult , Dermatitis Herpetiformis/pathology , Pemphigus/pathology , Fluorescent Antibody Technique, Direct/methods , Biopsy , Erythema/pathology
8.
An Bras Dermatol ; 91(1): 17-22, 2016.
Article in English | MEDLINE | ID: mdl-26982773

ABSTRACT

BACKGROUND: Among the chronic leg ulcers, venous ulcers are the most common and constitute a major burden to public health. Despite all technology available, some patients do not respond to established treatments. In our study, carboxymethylcellulose was tested in the treatment of refractory chronic venous ulcers. OBJECTIVE: To evaluate the efficacy of carboxymethylcellulose 20% on the healing of chronic venous ulcers refractory to conventional treatments. METHODS: This is an analytical, pre-experimental study. Thirty patients were included with refractory venous ulcers, and applied dressings with carboxymethylcellulose 20% for 20 weeks. The analysis was based on measurement of the area of ulcers, performed at the first visit and after the end of the treatment. RESULTS: There was a reduction of 3.9 cm2 of lesion area (p=0.0001), corresponding to 38.8% (p=0.0001). There was no interruption of treatment and no increase in lesion area in any patient. CONCLUSIONS: Carboxymethylcellulose 20% represents a low cost and effective therapeutic alternative for the treatment of refractory chronic venous ulcers. However, controlled studies are necessary to prove its efficacy.


Subject(s)
Carboxymethylcellulose Sodium/therapeutic use , Compression Bandages , Varicose Ulcer/drug therapy , Wound Healing/drug effects , Adult , Aged , Chronic Disease , Diabetes Mellitus/physiopathology , Female , Humans , Male , Middle Aged , Statistics, Nonparametric , Time Factors , Treatment Outcome
9.
An. bras. dermatol ; 91(1): 17-22, Jan.-Feb. 2016. tab
Article in English | LILACS | ID: lil-776427

ABSTRACT

Abstract BACKGROUND: Among the chronic leg ulcers, venous ulcers are the most common and constitute a major burden to public health. Despite all technology available, some patients do not respond to established treatments. In our study, carboxymethylcellulose was tested in the treatment of refractory chronic venous ulcers. OBJECTIVE: To evaluate the efficacy of carboxymethylcellulose 20% on the healing of chronic venous ulcers refractory to conventional treatments. METHODS: This is an analytical, pre-experimental study. Thirty patients were included with refractory venous ulcers, and applied dressings with carboxymethylcellulose 20% for 20 weeks. The analysis was based on measurement of the area of ulcers, performed at the first visit and after the end of the treatment. RESULTS: There was a reduction of 3.9 cm2 of lesion area (p=0.0001), corresponding to 38.8% (p=0.0001). There was no interruption of treatment and no increase in lesion area in any patient. CONCLUSIONS: Carboxymethylcellulose 20% represents a low cost and effective therapeutic alternative for the treatment of refractory chronic venous ulcers. However, controlled studies are necessary to prove its efficacy.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Compression Bandages , Carboxymethylcellulose Sodium/therapeutic use , Varicose Ulcer/drug therapy , Wound Healing/drug effects , Chronic Disease , Diabetes Mellitus/physiopathology , Statistics, Nonparametric , Time Factors , Treatment Outcome
10.
An Bras Dermatol ; 90(2): 276-8, 2015.
Article in English | MEDLINE | ID: mdl-25831007

ABSTRACT

Shiitake Dermatitis is a skin eruption that resembles whiplash marks and occurs after consumption of raw shiitake mushrooms. It is caused by a toxic reaction to lentinan, a thermolabil polysaccharide which decomposes upon heating. We report the second case of this dermatitis in Brazil. A 25-year-old man presented with linearly arranged erythematous, pruritic papules on the trunk and limbs, after ingestion of a salad containing raw shiitake mushrooms. The eruption was self-limited, resolving within 10 days of onset. The recognition of this entity gains importance due to the increased consumption of shiitake mushrooms in occidental countries.


Subject(s)
Dermatitis/etiology , Erythema/chemically induced , Mushroom Poisoning/complications , Shiitake Mushrooms , Adult , Dermatitis/pathology , Erythema/pathology , Humans , Male , Mushroom Poisoning/pathology
11.
Acta Dermatovenerol Croat ; 15(2): 65-71, 2007.
Article in English | MEDLINE | ID: mdl-17631783

ABSTRACT

Cutaneous aging is a complex biological phenomenon, dependent not only on the innate or intrinsic process ("biological clock"), but also on extrinsic elements, primarily chronic sun exposure (photoaging). In order to verify dermal morphological changes in the elastic fiber system and collagen associated with aged skin, we performed a light and electron microscopic study on exposed-shaved albino mice, which were exposed to UVB radiation. The experimental group consisted of 48 exposed animals, randomly distributed in three groups and submitted to different radiation doses (A, 28800 J/m2; B, 57600 J/m2; and C, 86400 J/m2) and studied 0, 30, 60 and 90 days of exposure discontinuation. Nonexposed-shaved and nonexposed-nonshaved animals were included as controls. From the day of exposure discontinuation and subsequently, the elastic system and collagen network were progressively modified. The increase in collagen fibril diameter was prominent in the 60 and 90 day groups (p<0.05), as noticed on electron microscopy. Elastic fiber density also increased after irradiation (p<0.05). On electron microscopy, elastogenesis was seen in the deep dermis. The comparative study among the groups disclosed clear relationship between doses and "elastotic changes". It also showed that chronological aging of mice skin was apparently intensified after UVB exposure. Skin elastogenesis seems to be a major consequence of UVB exposure, apart from elastolysis, and occurs not only in humans but also in hairless mice submitted to continuous, long-term UVB exposure.


Subject(s)
Dermis/radiation effects , Fibrillar Collagens/radiation effects , Ultraviolet Rays , Animals , Dermis/physiopathology , Dermis/ultrastructure , Elasticity/radiation effects , Fibrillar Collagens/physiology , Fibrillar Collagens/ultrastructure , Mice , Mice, Inbred BALB C , Radiation Dosage , Skin Aging/radiation effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...